MODEL RELEASED. Treatment for macular degeneration. Pronged marker being used on a patient's eye to indicate the injection point (4 millimetres from the iris) during treatment for age-related macular degeneration (AMD). Retractors are being used to hold back the eyelids,the eye has been cleaned with iodine eyedrops,and the eye has been numbed with local anaesthetic. Once the injection point has been located,a syringe will be used to inject Lucentis (ranibizumab). This is a monoclonal antibody that treats the vascular damage to the retina seen in AMD. Lucentis prevents abnormal retinal blood vessels forming,and dries up leaking blood vessels | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Marazzi, Dr. P. |
Bildgröße: | 5138 px × 3425 px |
Modell-Rechte: | vorhanden |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: |
|